Post by J&J Innovative Medicine Europe, Middle East & Africa (EMEA)

From the 11th to 14th of June, we’ll join researchers, healthcare professionals, patient advocates and partners from across the global haematology community at #EHA2026 in Stockholm, Sweden, to discuss the latest advances in haematology and collaborate on what’s next for patients. Our teams will present practice-changing data and real-world evidence, including innovations in immune-based treatment approaches that reflect our commitment to progressing the next wave of breakthroughs for people with blood cancer. And behind every breakthrough is something bigger than scientific progress. It’s an opportunity for more time and more moments that matter for patients and their loved ones. Watch the video below to hear how Johnson & Johnson colleagues and scientists are striving to get #InFrontofCancer. #EHA2026 #Hematology #InFrontofCancer

Video Content